News | Magnetic Resonance Imaging (MRI) | January 09, 2020

MR Solutions Grows Support Network

With more than 2,000 sites across the globe, MR Solutions is now present on every continent bar Antarctica

MR Solutions cryogen free preclinical MRI

January 9, 2020 — MR Solutions is continuing to expand its support network as its base of preclinical liquid helium free multimodality MRI systems become the norm in research laboratories across the world.

MR Solutions has multiple distributors in Japan, Korea, Australia and China. In Europe and Russia there are not only multiple distributors but also specialist engineers. In North America MR Solutions has a U.S. sales office, distributors and specialist engineers. South American sites are supported through three distributors.

As well as this growing network of distributors and specialist engineers, MR Solutions’ head office in the UK provides around the clock support through its online links with every installed system. 

With more than 2,000 sites across the globe, which includes spectrometers - the brains of any scanner system - MR Solutions is now present on every continent bar Antarctica.

Fabrice Chaumard, sales director, commented, “We are very conscious that in the rare event of one of our systems requiring a specialist technician on site that assistance should be close by. We will continue to expand our network to ensure we offer best in class support.”

MR Solutions has become the leading force in preclinical scanning through continuous innovation including liquid helium free, high field MRI scanners, solid state clip on PET, ringless detectors and recently a range of state of the art multi-modality CT scanners. MR Solutions remains the only company with an installed base of multi-modality, liquid helium free MRI systems.

All of the 28 models of preclinical scanners share a common animal handling solution so that transfers between different types of scanner is quick and easy.

MR Solutions, based in the UK, has over 30 years’ experience and in excess of 2,000 installations including spectrometer sales across the world. MR Solutions holds the prestigious Queen’s Awards for Enterprise, achieving this for Innovation in 2016 and 2019 and for International Trade in 2017. Its scanners are renowned for their excellence in terms of superior soft tissue contrast and molecular imaging ability.

For more information: www.mrsolutions.com

Related Content

Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries

Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries 

Feature | Radiology Imaging | September 17, 2020 | By Robert Bard, M.D. PC, DABR, FASLM
COVID-19 is routinely studied using...
 A cardiac MRI is effective in identifying inflammation of the heart muscle in athletes and can help determine when those who have recovered from COVID-19 can safely return to play in competitive sports, according to a new study by researchers at The Ohio State University Wexner Medical Center.

Getty Images

News | Cardiac Imaging | September 14, 2020
September 14, 2020 — A...
All intensive care unit equipment, including ventilators, pumps, and monitoring devices, as well as the point-of-care magnetic resonance image operator and bedside nurse, remained in the room. All equipment was operational during scanning.

All intensive care unit equipment, including ventilators, pumps, and monitoring devices, as well as the point-of-care magnetic resonance image operator and bedside nurse, remained in the room. All equipment was operational during scanning. Image courtesy of JAMA Neurology

News | Magnetic Resonance Imaging (MRI) | September 11, 2020
September 11, 2020 — A portable, low-field...
Six months after deployment, the no-show rate of the predictive model was 15.9%, compared with 19.3% in the preceding 12-month preintervention period — corresponding to a 17.2% improvement from the baseline no-show rate (p < 0.0001). The no-show rates of contactable and noncontactable patients in the group at high risk of appointment no-shows as predicted by the model were 17.5% and 40.3%, respectively (p < 0.0001).

Weekly outpatient MRI appointment no-show rates for 1 year before (19.3%) and 6 months after (15.9%) implementation of intervention measures in March 2019, as guided by XGBoost prediction model. Squares denote data points. Courtesy of the  American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Artificial Intelligence | September 10, 2020
September 10, 2020 — According to ARRS’
Vantage Galan with Advanced intelligent Clear-IQ Engine (AiCE) provides high-quality images and fast exam times

Coronal orbit images: Left original and right with AiCE.

News | Magnetic Resonance Imaging (MRI) | September 09, 2020
September 9, 2020
The global pediatric imaging market size is expected to reach $12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc.

Getty Images

News | Pediatric Imaging | August 26, 2020
August 26, 2020 — The global ...
AI-Rad Companion Prostate MR for Biopsy Support segments prostate for targeted biopsy under MRI and ultrasound fusion imaging

Image courtesy of Clinica Universidad de Navarra, Spain

News | Artificial Intelligence | August 19, 2020
August 19, 2020 — The Food and Drug Administration (FDA) has cleared two additional...
The first and only FDA-approved gadolinium-based contrast agent for multi-patient dosing with an FDA-cleared Transfer Spike in the MR suite
News | Contrast Media | August 14, 2020
August 14, 2020 — The U.S.
Videos | Cardiac Imaging | August 12, 2020
Advanced visualization company...